Incannex Healthcare Ltd
ASX:IHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SSAB AB
STO:SSAB A
|
SE |
|
Z
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
|
CN |
Incannex Healthcare Ltd
EPS (Diluted)
Incannex Healthcare Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Incannex Healthcare Ltd
ASX:IHL
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
29%
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
EPS (Diluted)
-AU$1
|
CAGR 3-Years
30%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Incannex Healthcare Ltd
Glance View
Incannex Healthcare Ltd. is a cannabinoid and psychedelic compound medicine development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The company is a clinical stage pharmaceutical development company. The firm is engaged in developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies. Its product candidate IHL-42X is developing a combination of acetazolamide and dronabinol to reduce the apnea hypopnea index (AHI), IHL-216A is a combination of isoflurane and CBD to prevent development of traumatic brain injury (TBI)/concussion, HL-675A comprises a combination of hydroxychloroquine and CBD in prevention and treatment of inflammatory lung conditions (ARDS, COPD, asthma, and bronchitis), rheumatoid arthritis and inflammatory bowel diseases and Psi-GAD is providing Psychedelic-assisted psychotherapy for Generalized Anxiety Disorder (GAD).
See Also
What is Incannex Healthcare Ltd's EPS (Diluted)?
EPS (Diluted)
-0
AUD
Based on the financial report for Jun 30, 2023, Incannex Healthcare Ltd's EPS (Diluted) amounts to -0 AUD.
What is Incannex Healthcare Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
29%
Over the last year, the EPS (Diluted) growth was 0%.
